(PHG) Koninklijke Philips - Ratings and Ratios
Medical Imaging Systems, Health Care Solutions, Personal Care Products
PHG EPS (Earnings per Share)
PHG Revenue
Description: PHG Koninklijke Philips
Koninklijke Philips NV ADR (NYSE:PHG) is a health technology company operating globally, with a diversified portfolio across three main segments: Diagnosis & Treatment, Connected Care, and Personal Health. The company offers a range of innovative medical imaging and diagnostic solutions, including MRI, CT, and ultrasound systems, as well as patient care management and monitoring solutions.
From a financial perspective, Philips has a market capitalization of $22.35 billion, indicating a significant presence in the healthcare industry. The companys P/E ratio of 77.68 suggests that the stock may be overvalued relative to its earnings, but the forward P/E ratio of 13.72 indicates potential for growth. The Return on Equity (RoE) of 3.14% is relatively low, suggesting that the company may not be generating sufficient profits from shareholder equity.
To further analyze Philips performance, we can examine additional KPIs. For instance, the companys revenue growth rate, gross margin, and operating margin can provide insights into its financial health. Philips debt-to-equity ratio and interest coverage ratio can also help assess its capital structure and ability to meet debt obligations. Furthermore, metrics such as the dividend yield and payout ratio can be useful for income investors. By examining these KPIs, we can gain a more comprehensive understanding of Philips strengths and weaknesses.
Some key performance indicators (KPIs) to monitor for Philips include: Revenue Growth Rate (historical and projected), Gross Margin, Operating Margin, Debt-to-Equity Ratio, Interest Coverage Ratio, Dividend Yield, and Payout Ratio. By analyzing these metrics, investors can make more informed decisions about the companys potential for long-term growth and returns.
PHG Stock Overview
| Market Cap in USD | 26,550m |
| Sub-Industry | Health Care Equipment |
| IPO / Inception | 1987-12-30 |
PHG Stock Ratings
| Growth Rating | 16.4% |
| Fundamental | 58.5% |
| Dividend Rating | 26.0% |
| Return 12m vs S&P 500 | -20.3% |
| Analyst Rating | 4.0 of 5 |
PHG Dividends
| Dividend Yield 12m | 3.64% |
| Yield on Cost 5y | 2.41% |
| Annual Growth 5y | -0.45% |
| Payout Consistency | 74.8% |
| Payout Ratio | 69.2% |
PHG Growth Ratios
| Growth Correlation 3m | 94.4% |
| Growth Correlation 12m | -26% |
| Growth Correlation 5y | -42.8% |
| CAGR 5y | 21.58% |
| CAGR/Max DD 3y | 0.64 |
| CAGR/Mean DD 3y | 1.91 |
| Sharpe Ratio 12m | 0.49 |
| Alpha | 0.00 |
| Beta | 0.987 |
| Volatility | 28.88% |
| Current Volume | 572.5k |
| Average Volume 20d | 609.1k |
| Stop Loss | 27 (-3.3%) |
| Signal | -0.54 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (162.0m TTM) > 0 and > 6% of Revenue (6% = 1.07b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -2.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.43% (prev 7.59%; Δ 2.84pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 1.09b > Net Income 162.0m (YES >=105%, WARN >=100%) |
| Net Debt (6.60b) to EBITDA (2.21b) ratio: 2.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (956.7m) change vs 12m ago 1.58% (target <= -2.0% for YES) |
| Gross Margin 43.85% (prev 41.56%; Δ 2.29pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 63.94% (prev 61.52%; Δ 2.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.53 (EBITDA TTM 2.21b / Interest Expense TTM 323.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.35
| (A) 0.07 = (Total Current Assets 9.06b - Total Current Liabilities 7.20b) / Total Assets 26.38b |
| (B) 0.12 = Retained Earnings (Balance) 3.03b / Total Assets 26.38b |
| (C) 0.04 = EBIT TTM 1.14b / Avg Total Assets 27.93b |
| (D) 0.22 = Book Value of Equity 3.57b / Total Liabilities 15.97b |
| Total Rating: 1.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.46
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 0.96% = 0.48 |
| 3. FCF Margin 1.56% = 0.39 |
| 4. Debt/Equity 0.81 = 2.18 |
| 5. Debt/Ebitda 3.82 = -2.47 |
| 6. ROIC - WACC (= 6.58)% = 8.22 |
| 7. RoE 1.41% = 0.12 |
| 8. Rev. Trend -20.17% = -1.51 |
| 9. EPS Trend 21.17% = 1.06 |
What is the price of PHG shares?
Over the past week, the price has changed by -1.22%, over one month by +2.99%, over three months by +28.15% and over the past year by -4.74%.
Is Koninklijke Philips a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PHG is around 26.14 USD . This means that PHG is currently overvalued and has a potential downside of -6.38%.
Is PHG a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the PHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.8 | 17.4% |
| Analysts Target Price | 32.8 | 17.4% |
| ValueRay Target Price | 29.5 | 5.5% |
Last update: 2025-09-09 04:44
PHG Fundamental Data Overview
CCE Cash And Equivalents = 1.82b EUR (last quarter)
P/E Trailing = 147.0
P/E Forward = 14.7059
P/S = 1.487
P/B = 2.1939
P/EG = 0.3632
Beta = 0.832
Revenue TTM = 17.86b EUR
EBIT TTM = 1.14b EUR
EBITDA TTM = 2.21b EUR
Long Term Debt = 7.18b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.24b EUR (from shortTermDebt, last quarter)
Debt = 8.43b EUR (Calculated: Short Term 1.24b + Long Term 7.18b)
Net Debt = 6.60b EUR (from netDebt column, last quarter)
Enterprise Value = 29.07b EUR (22.47b + Debt 8.43b - CCE 1.82b)
Interest Coverage Ratio = 3.53 (Ebit TTM 1.14b / Interest Expense TTM 323.0m)
FCF Yield = 0.96% (FCF TTM 279.0m / Enterprise Value 29.07b)
FCF Margin = 1.56% (FCF TTM 279.0m / Revenue TTM 17.86b)
Net Margin = 0.91% (Net Income TTM 162.0m / Revenue TTM 17.86b)
Gross Margin = 43.85% ((Revenue TTM 17.86b - Cost of Revenue TTM 10.03b) / Revenue TTM)
Tobins Q-Ratio = 8.13 (Enterprise Value 29.07b / Book Value Of Equity 3.57b)
Interest Expense / Debt = 0.95% (Interest Expense 80.0m / Debt 8.43b)
Taxrate = 782.9% (set to none) (963.0m / 123.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.26 (Total Current Assets 9.06b / Total Current Liabilities 7.20b)
Debt / Equity = 0.81 (Debt 8.43b / last Quarter total Stockholder Equity 10.38b)
Debt / EBITDA = 3.82 (Net Debt 6.60b / EBITDA 2.21b)
Debt / FCF = 30.20 (Debt 8.43b / FCF TTM 279.0m)
Total Stockholder Equity = 11.49b (last 4 quarters mean)
RoA = 0.61% (Net Income 162.0m, Total Assets 26.38b )
RoE = 1.41% (Net Income TTM 162.0m / Total Stockholder Equity 11.49b)
RoCE = 6.10% (Ebit 1.14b / (Equity 11.49b + L.T.Debt 7.18b))
RoIC = 6.58% (Ebit 1.14b / (Assets 26.38b - Current Assets 9.06b))
WACC = unknown (E(22.47b)/V(30.89b) * Re(9.65%)) + (D(8.43b)/V(30.89b) * Rd(0.95%) * (1-Tc(none)))
Shares Correlation 3-Years: 38.17 | Cagr: 0.71%
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.55% ; FCFE base≈589.0m ; Y1≈386.7m ; Y5≈176.8m
Fair Price DCF = 2.86 (DCF Value 2.72b / Shares Outstanding 950.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 21.17 | EPS CAGR: 5.27% | SUE: -0.37 | # QB: 0
Revenue Correlation: -20.17 | Revenue CAGR: 0.24% | SUE: 0.00 | # QB: 0
Additional Sources for PHG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle